The ETF tracks the American Customer Satisfaction Investable Index. This benchmark employs proprietary metrics to evaluate ...
MoonLake Immunotherapeutics (NASDAQ: MLTX) (MoonLake or the Company), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announces ...
DURHAM, N.C., March 28, 2026 (GLOBE NEWSWIRE) -- Priovant Therapeutics, a clinical-stage biotechnology company focused on developing targeted therapeutics in autoimmune disease, announced today the ...
The biotechnology firm Prime Medicine is approaching what could be its most definitive period. Following its 2025 annual results, the company is shifting its strategic emphasis from initial clinical ...
The company formerly known as Digital Development Partners has now officially completed its rebranding to Black Bird Biotech. This finalizes a significant corporate transformation, shifting investor ...
Australian Vanadium Ltd. is making significant strides toward establishing an integrated supply chain in Western Australia. A key development is the company's exclusive alliance with Japan's Sumitomo ...
Nearly two decades after its collapse sent shockwaves through global financial markets, the winding-up of Lehman Brothers is entering its conclusive phase. A specific date has now been set for the ...
EQS-DD: Infineon Technologies AG: Jochen Hanebeck, Übertragung von Aktien im Rahmen des Infineon-Performance Share Plans ^ Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die ...
New York (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von TD Cowen: Die Analysten von TD Cowen stufen die Aktie von Hims & Hers Health Inc. (ISIN: US4330001060, WKN: A2QMYY, Ticker-Symbol: ...
Die Aktie von Rio Tinto plc (ISIN: GB0007188757, WKN: 852147, Ticker-Symbol: RIO1, London Stock Exchange-Symbol: RIO) steht derzeit im Fokus institutioneller Investoren und Analysten. Nachdem der ...
Die Aktie von The Kraft Heinz Company (ISIN: US5007541064, WKN: A14TU4, Ticker-Symbol: KHNZ, NASDAQ-Symbol: KHC) gehört seit Jahren zu den umstrittensten Titeln im Konsumgütersektor – stabil, aber sel ...
Frankfurt (www.aktiencheck.de) - Deutsche Börse AG-Aktienanalyse von XTB: Die Aktie der Deutsche Börse AG (ISIN: DE0005810055, WKN: 581005, Ticker-Symbol: DB1, NASDAQ OTC-Symbol: DBOEF) rückt ...